Sigrid Cornelis

Title: Sigrid Cornelis: Innovator in Biotechnology

Introduction

Sigrid Cornelis is a prominent inventor based in Gent, Belgium. She has made significant contributions to the field of biotechnology, particularly through her innovative research and patents. Her work focuses on the mechanisms of protein translation and the regulation of cellular processes.

Latest Patents

Sigrid Cornelis holds a patent titled "Internal ribosome entry site, vector containing same and uses thereof." This patent describes the translation of two isoforms, p110 and p58, of the PITSLRE protein kinase from a single mRNA species through an internal ribosome entry process. The discovery that these proteins can be translated from the same mRNA using two AUGs within the same reading frame is groundbreaking. The internal ribosomal entry site (IRES) identified in the polycistronic p110 mRNA is the first of its kind to be completely localized in the coding region of a cellular mRNA. Additionally, it was found that the IRES element is regulated by the cell cycle, with translation of p58 occurring specifically during the G2/M stage.

Career Highlights

Sigrid Cornelis is affiliated with the Vlaams Interuniversitair Instituut Voor Biotechnologie, where she conducts her research. Her work has garnered attention for its implications in understanding protein synthesis and its regulation in cellular processes.

Collaborations

Sigrid collaborates with Rudi Beyaert, a fellow researcher in the field. Their partnership has contributed to advancements in biotechnology and the understanding of protein functions.

Conclusion

Sigrid Cornelis is a notable inventor whose work in biotechnology has led to significant advancements in understanding protein translation and regulation. Her contributions continue to influence the field and inspire future research.